What changed
$MO — HOLD 📊 | 6 MONTHS THESIS
🎯 Q1 2026 | Rev $5.4B | EPS $1.32 vs $1.25 🟢 | Margin 54.5%
💡 No meaningful gap. Consensus expected low-single-digit decline or flat growth; the beat and reaffirmed guidance of 2.5-5.5% adjusted EPS growth met rather than exceeded these muted expectations. Market-implied forward P/E of ~12x is fair given secular volume erosion.
📉 Reward/risk: 1.25:1
🏢 Business Quality: 7/10/10 - Dominant U.S. tobacco franchise with pricing power and massive cash flow, but structural cigarette volume decline (mid-single-digit annually) and persistent regulatory overhang cap the premium.
📊 Valuation: fair — forward P/E 12.2x vs 15.2x historical median and 15-18x consumer staples peer group, but justified by negative unit growth.
📊 Our read: HOLD. Full analysis →
https://stockduty.xyz/s/MO0618